MiR-410 regulates MET to influence the proliferation and invasion of glioma-Reference-Cited by-同舟云学术

MiR-410 regulates MET to influence the proliferation and invasion of glioma

Published:2012-11 Issue:11 Volume:44 Page:1711-1717
ISSN:1357-2725
Container-title:The International Journal of Biochemistry & Cell Biology
language:en
Short-container-title:The International Journal of Biochemistry & Cell Biology

Author:

Chen Lingchao,Zhang Junhe,Feng Yan,Li Ruiyan,Sun Xu,Du Wenzhong,Piao Xinyin,Wang Hanbing,Yang Dongbo,Sun Ying,Li Xianfeng,Jiang Tao,Kang Chunsheng,Li Yongli,Jiang Chuanlu

Publisher

Elsevier BV

Subject

Cell Biology,Biochemistry

Reference31 articles.

1. Colon cancer metastasis: Macc1 and met as metastatic pacemakers;Arlt;International Journal of Biochemistry and Cell Biology,2009

2. Met, metastasis, motility and more;Birchmeier;Nature Reviews Molecular Cell Biology,2003

3. Diagnosis and treatment of recurrent high-grade astrocytoma;Butowski;Journal of Clinical Oncology,2006

4. Microrna signatures in human cancers;Calin;Nature Reviews Cancer,2006

5. Targeting the hgf/met signalling pathway in cancer;Cecchi;European Journal of Cancer,2010

Cited by 86 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Regulatory role of miR‐125a expression with respect to its target genes LIFR, ERBB2 and STAT3 in the pathogenesis of recurrent pregnancy losses;International Journal of Gynecology & Obstetrics;2024-03-25

2. DNA methylation-mediated repression of microRNA-410 promotes the growth of human glioma cells and triggers cell apoptosis through its interaction with STAT3;Scientific Reports;2024-01-18

3. The effect of lymphocyte immunotherapy (LIT) in modulating immune responses in patients with recurrent pregnancy loss (RPL);International Immunopharmacology;2023-08

4. Circulating miRNAs as Diagnostic and Prognostic Biomarkers in High-Grade Gliomas;Frontiers in Oncology;2022-05-12

5. Genome-wide circular RNA (circRNA) and mRNA profiling identify a circMET-miR-410-3p regulatory motif for cell growth in colorectal cancer;Genomics;2022-01